Literature DB >> 12223521

Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway.

Yannick Le Meur1, Gregory H Tesch, Prudence A Hill, Wei Mu, Rita Foti, David J Nikolic-Paterson, Robert C Atkins.   

Abstract

Production of macrophage-colony stimulating factor (M-CSF), the major macrophage growth factor, is increased in tissues during inflammation. Therefore, we determined whether M-CSF, acting through its receptor c-fms, contributes to macrophage accumulation at a site of tissue injury. Daily treatment with anti-c-fms or control antibody was given to mice with renal inflammation resulting from unilateral ureteric obstruction (UUO). Following UUO, kidney M-CSF mRNA increased in association with macrophage accumulation (days 1, 5, and 10) and local macrophage proliferation (days 5 and 10). Anti-c-fms treatment caused a minor inhibition of monocyte recruitment at day 1, reduced macrophage accumulation by 75% at day 10, but did not affect blood monocyte counts or the CD4 and CD8 lymphocytic infiltrate. Prevention of macrophage accumulation by anti-c-fms treatment was associated with a 90% reduction in local macrophage proliferation at days 5 and 10 without evidence of increased macrophage apoptosis. Therefore, M-CSF/c-fms signaling plays a key role in macrophage accumulation during tissue injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223521

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  25 in total

1.  Distinct roles of CSF-1 isoforms in lupus nephritis.

Authors:  Julia Menke; Yasunori Iwata; Whitney A Rabacal; Ranu Basu; E Richard Stanley; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

2.  Nitro-oleic acid regulates growth factor-induced differentiation of bone marrow-derived macrophages.

Authors:  Hana Verescakova; Gabriela Ambrozova; Lukas Kubala; Tomas Perecko; Adolf Koudelka; Ondrej Vasicek; Tanja K Rudolph; Anna Klinke; Steven R Woodcock; Bruce A Freeman; Michaela Pekarova
Journal:  Free Radic Biol Med       Date:  2017-01-04       Impact factor: 7.376

3.  Proliferation of Ly6C+ monocytes/macrophages contributes to their accumulation in mouse skin wounds.

Authors:  Jingbo Pang; Norifumi Urao; Timothy J Koh
Journal:  J Leukoc Biol       Date:  2019-11-28       Impact factor: 4.962

Review 4.  Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.

Authors:  Abbas Mirshafiey; Ghasem Ghalamfarsa; Babak Asghari; Gholamreza Azizi
Journal:  Innov Clin Neurosci       Date:  2014-07

5.  Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.

Authors:  James G Conway; Brad McDonald; Janet Parham; Barry Keith; David W Rusnak; Eva Shaw; Marilyn Jansen; Peiyuan Lin; Alan Payne; Renae M Crosby; Jennifer H Johnson; Lloyd Frick; Min-Hwa Jasmine Lin; Scott Depee; Sarva Tadepalli; Bart Votta; Ian James; Karen Fuller; Timothy J Chambers; Frederick C Kull; Stanley D Chamberlain; Jeff T Hutchins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

Review 6.  Unilateral ureteral obstruction: beyond obstruction.

Authors:  Alvaro C Ucero; Alberto Benito-Martin; Maria C Izquierdo; Maria D Sanchez-Niño; Ana B Sanz; Adrian M Ramos; Sergio Berzal; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  Int Urol Nephrol       Date:  2013-09-27       Impact factor: 2.370

Review 7.  Oxidative stress in obstructive nephropathy.

Authors:  Amélie Dendooven; David A Ishola; Tri Q Nguyen; Dionne M Van der Giezen; Robbert Jan Kok; Roel Goldschmeding; Jaap A Joles
Journal:  Int J Exp Pathol       Date:  2010-08-27       Impact factor: 1.925

8.  Vav activation and function as a rac guanine nucleotide exchange factor in macrophage colony-stimulating factor-induced macrophage chemotaxis.

Authors:  Vidya Vedham; Hyewon Phee; K Mark Coggeshall
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

9.  Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor.

Authors:  Chao Zhang; Prabha N Ibrahim; Jiazhong Zhang; Elizabeth A Burton; Gaston Habets; Ying Zhang; Ben Powell; Brian L West; Bernice Matusow; Garson Tsang; Rafe Shellooe; Heidi Carias; Hoa Nguyen; Adhirai Marimuthu; Kam Y J Zhang; Angela Oh; Ryan Bremer; Clarence R Hurt; Dean R Artis; Guoxian Wu; Marika Nespi; Wayne Spevak; Paul Lin; Keith Nolop; Peter Hirth; Greg H Tesch; Gideon Bollag
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

10.  Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice.

Authors:  A K H Lim; F Y Ma; D J Nikolic-Paterson; M C Thomas; L A Hurst; G H Tesch
Journal:  Diabetologia       Date:  2009-05-23       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.